Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)

v3.23.3
Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Accounts receivables and contract assets, allowance for credit losses $ 24 $ 28
Long-term debt fair value $ 271 $ 237
Series A    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 200,000,000 200,000,000
Common stock shares issued 72,821,919 72,641,163
Common stock, shares outstanding 72,821,919 72,641,163
Series B    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 7,500,000 7,500,000
Common stock shares issued 3,737,475 3,370,368
Common stock, shares outstanding 3,737,475 3,370,368
Series C    
Equity:    
Common stock, par value per share $ 0.01 $ 0.01
Common stock, shares authorized 200,000,000 200,000,000
Common stock shares issued 0 0